Kelly Deck insider trades
Open-market stock purchases and sales by Kelly Deck, Chief Financial Officer at Inhibrx Biosciences, Inc, from SEC Form 4 filings since Jan 15, 2021.
Recent trades
No open-market trades in the last 12 months.
Open-market stock purchases and sales by Kelly Deck, Chief Financial Officer at Inhibrx Biosciences, Inc, from SEC Form 4 filings since Jan 15, 2021.
No open-market trades in the last 12 months.